The National Heart, Lung, and Blood Institute (NHLBI) awarded a $842,408 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to Inspire RX LLC to develop and evaluate the Aerosolve Biohelmet, a personal negative pressure device designed to safely transport and treat patients with highly transmissible respiratory infectious diseases, including COVID-19. The project aims to refine the Biohelmet design, conduct performance and safety testing, and deploy the device for clinical evaluations during ground and air ambulance transport of patients with suspected or confirmed communicable respiratory illnesses. This innovative solution is intended to provide a compact, portable, and cost-effective negative pressure environment to protect healthcare workers and enable necessary patient treatments outside of limited hospital resources.
Generated 1/28/25, 10:57 AM